Our results demonstrated that the level of FAM64A was progressively increased from normal to dysplastic to cancerous tissues, indicating that FAM64A acts as a key player in driving HNSCC onset and progression (Fig. S9a–c). Here, PIMREG is linked to head and neck squamous cell carcinoma.